doi: 10.1016/j.celrep.2015.06.062 204 WangY
Benefits for Heart, Kidney and Brain Health GLP-1 agonists and SGLT2 inhibitors, both used in managing Type 2 diabetes, show distinct impacts on the heart, kidneys, and brain: Cardiovascular and Renal Effects: SGLT2 inhibitors, such as empagliflozin, significantly reduce the risk of heart failure and cardiovascular mortality in Type 2 diabetes patients
When toxins, microbes, and undigested food particles escape through your gut and into your bloodstream, your immune system attacks them, allowing bacteria to overgrow in your small intestine
Keremi B et al
When diarrhea occurs, it is usually most noticeable in the early stages of treatment
Yet emerging evidence suggests they may also have neuroprotective properties